These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28783143)

  • 1. Unrelated cord blood transplantation in aplastic anemia: is anti-thymocyte globulin indispensable for conditioning?
    Kudo K; Muramatsu H; Narita A; Yoshida N; Kobayashi R; Yabe H; Endo M; Inoue M; Hara J; Kounami S; Inagaki J; Hashii Y; Kato K; Tabuchi K; Kojima S
    Bone Marrow Transplant; 2017 Dec; 52(12):1659-1661. PubMed ID: 28783143
    [No Abstract]   [Full Text] [Related]  

  • 2. Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series.
    Hu M; Li J; Liu R; Zhang Z; Feng S; Zhong D; Tang R; Xuan L
    Ann Hematol; 2024 Jun; 103(6):2103-2111. PubMed ID: 38656370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
    McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
    Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study.
    Peffault de Latour R; Chevret S; Jubert C; Sirvent A; Galambrun C; Ruggeri A; Gandemer V; Cornillon J; Rialland F; Dalle JH; Forcade E; Bruno B; Paillard C; Rorlich PS; Salmon A; Fürst S; Sicre de Fontbrune F; Rubio MT; Bay JO; Mohty M; Larghero J; Gluckman E; Socié G;
    Blood; 2018 Aug; 132(7):750-754. PubMed ID: 29760162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies.
    Kang HJ; Hong KT; Lee JW; Kim H; Park KD; Shin HY; Lee SH; Yoo KH; Sung KW; Koo HH; Lee JW; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Jung HJ; Park JE; Lee YH; Lim YT; Lim YJ; Kim SY; Yoo ES; Ryu KH; Lee JH; Park JA; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1455-1459. PubMed ID: 27090956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia.
    Koh KN; Im HJ; Kim BE; Choi ES; Jang S; Kwon SW; Park CJ; Seo JJ
    Br J Haematol; 2012 Apr; 157(1):139-42. PubMed ID: 22055111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects of anti-thymocyte globulin/anti-lymphocyte globulin therapy].
    Kobayashi R; Kaneda M; Watanabe N; Iguchi A; Cho Y; Yoshida M; Arioka H; Naito H; Shikano T; Ishikawa Y
    Rinsho Ketsueki; 1999 Jul; 40(7):531-5. PubMed ID: 10483134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.
    Bacigalupo A; Locatelli F; Lanino E; Marsh J; Socié G; Maury S; Prete A; Locasciulli A; Cesaro S; Passweg J;
    Bone Marrow Transplant; 2005 Dec; 36(11):947-50. PubMed ID: 16205733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
    Ayas M; Al-Seraihi A; El-Solh H; Al-Ahmari A; Khairy A; Aldali A; Markiz S; Siddiqui K; Al-Jefri A
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical-cord blood cell transplantation conditioned with a reduced intensity-regimen is a practical salvage therapy for severe aplastic anemia refractory to immunosuppressive therapy with antithymocyte globulin/ciclosporin.
    Tajika K; Mizuki T; Nakayama K; Yamaguchi H; Dan K
    J Nippon Med Sch; 2007 Dec; 74(6):424-9. PubMed ID: 18084137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia.
    Maury S; Balère-Appert ML; Pollichieni S; Oneto R; Yakoub-Agha I; Locatelli F; Dalle JH; Lanino E; Fischer A; Pession A; Huynh A; Barberi W; Mohty M; Risitano A; Milpied N; Socié G; Bacigalupo A; Marsh J; Passweg JR;
    Am J Hematol; 2013 Oct; 88(10):868-73. PubMed ID: 23804195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic cell transplantation for severe aplastic anemia: similar long-term overall survival after transplantation with related donors compared to unrelated donors.
    Mortensen BK; Jacobsen N; Heilmann C; Sengeløv H
    Bone Marrow Transplant; 2016 Feb; 51(2):288-90. PubMed ID: 26437067
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation for severe aplastic anemia: graft rejection remains a problem.
    Aki SZ; Sucak GT; Ozkurt ZN; Yeğin ZA; Yağci M; Haznedar R
    Transfus Apher Sci; 2009 Feb; 40(1):5-11. PubMed ID: 19121979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapy.
    Mao P; Wang S; Wang S; Zhu Z; Liv Q; Xuv Y; Mo W; Ying Y
    Bone Marrow Transplant; 2004 Jan; 33(1):33-8. PubMed ID: 14704655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Side effects and strategy in treating pediatric patients with aplastic anemia with anti-thymocyte globulin].
    Wu W; Shen HP; Zhao FY
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):383-4. PubMed ID: 16780721
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
    Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
    Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG.
    Kim H; Lee KH; Kim I; Sohn SK; Jung CW; Joo YD; Kim SH; Kim BS; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Lee WS; Oh S; Kim HJ; Park JH;
    Leuk Res; 2014 Jul; 38(7):730-6. PubMed ID: 24840870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.
    Osugi Y; Yagasaki H; Sako M; Kosaka Y; Taga T; Ito T; Yamamoto M; Ohara A; Sato T; Mimaya J; Tsukimoto I; Kojima S;
    Haematologica; 2007 Dec; 92(12):1687-90. PubMed ID: 18055993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.